Back to SUPN overview

SUPN Supernus Pharmaceuticals PE ratio, current and historical analysis

The current P/E ratio of SUPN cannot be calculated, as the latest EPS of -$0.29 is negative. The last recorded PE ratio for Supernus Pharmaceuticals was 1447.0 in December 2023.

SUPN PE ratio history

How has SUPN's PE ratio performed in the past

The average historical PE ratio of Supernus Pharmaceuticals for the last ten years is 71.5. Analyzing the last ten years, SUPN's PE ratio reached its highest point in the Dec 2023 quarter at 1,447, when the price was $28.94 and the EPS was $0.02. The lowest point was recorded in the Mar 2020 quarter, when it reached 8.14 with a price of $17.99 and an EPS of $2.21.


Supernus Pharmaceuticals PE ratio by year

Maximum annual increase: 4,483.47% in 2023

Maximum annual decrease: -70.39% in 2016

Year PE ratio Change
2023 1,447 4,483.47%
2022 31.57 9.35%
2021 28.87 176.53%
2020 10.44 -4.92%
2019 10.98 -29.62%
2018 15.6 -55.77%
2017 35.27 157.07%
2016 13.72 -70.39%
2015 46.34 N/A
2014 N/A N/A

SUPN average PE ratio chart

What is the average PE ratio of SUPN for the past years
3-year avg
5-year avg
10-year avg
15-year avg

SUPN PE vs peers

What is SUPN's PE ratio compared to its peers
Stock name PE ratio Market cap
JNJ Johnson & Johnson 10.18 $373.83B
ABT Abbott Laboratories 32.49 $182.56B
LLY ELI LILLY & Co 133.91 $868B
BMY Bristol Myers Squibb Co N/A $87.91B
SUPN Supernus Pharmaceuticals Inc N/A $1.61B

Frequently asked questions

What is Supernus Pharmaceuticals's PE ratio?

The current price to earnings ratio of SUPN cannot be determined, as its EPS of -$0.29 is negative.

What is the 3-year average PE ratio for Supernus Pharmaceuticals (SUPN)?

Over the last 3 years, the average PE ratio for SUPN stock is 175.66.

What is the 5-year average PE ratio for Supernus Pharmaceuticals (SUPN)?

Over the last 5 years, the average PE ratio for SUPN stock is 102.64.

What is the highest PE ratio for SUPN?

The highest quarterly PE ratio in the last ten years has been 1,447 and it was in the Dec 2023 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.